Jesús Lorenzo Algarra

Hospital General de Albacete
Hermanos Falcó, 37
Semisótano Hospital General de Albacete
Albacete ESP 02006
Papers:
433 Role of Measurable Residual Disease (MRD) in Redefining Complete Response (CR) in Elderly Patients with Acute Myeloid Leukemia (AML): Results from the Pethema-Flugaza Phase III Clinical Trial